Ana Matos

576 total citations
26 papers, 345 citations indexed

About

Ana Matos is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ana Matos has authored 26 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Ana Matos's work include Systemic Lupus Erythematosus Research (7 papers), Pharmacological Effects of Natural Compounds (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Ana Matos is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Pharmacological Effects of Natural Compounds (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Ana Matos collaborates with scholars based in Portugal, Italy and Netherlands. Ana Matos's co-authors include Carla Henriques, Luís Inês, Diogo Jesús, José António Pereira da Silva, Andrea Doria, Maddalena Larosa, Margherita Zen, Luca Iaccarino, Marc A. Seelen and Bernardo Faria and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and American Heart Journal.

In The Last Decade

Ana Matos

23 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Matos Portugal 10 169 152 69 56 41 26 345
J Dimitrijević Serbia 8 119 0.7× 68 0.4× 110 1.6× 45 0.8× 8 0.2× 48 309
Keith Tse China 10 263 1.6× 94 0.6× 282 4.1× 43 0.8× 13 0.3× 25 504
Silvia Mura Italy 12 48 0.3× 44 0.3× 47 0.7× 25 0.4× 75 1.8× 17 475
Haruyo Iwadate Japan 11 171 1.0× 56 0.4× 18 0.3× 10 0.2× 27 0.7× 25 316
Gudrun Norby Norway 8 117 0.7× 65 0.4× 107 1.6× 20 0.4× 8 0.2× 10 293
Stéphane Gayet France 9 186 1.1× 45 0.3× 40 0.6× 24 0.4× 16 0.4× 14 346
Samuel H. Belok United States 5 31 0.2× 147 1.0× 249 3.6× 37 0.7× 15 0.4× 10 399
Alison Balfour United States 7 101 0.6× 158 1.0× 159 2.3× 16 0.3× 6 0.1× 11 348
See Cheng Yeo Singapore 12 45 0.3× 77 0.5× 336 4.9× 14 0.3× 28 0.7× 25 453
Ken‐ichi Samejima Japan 12 41 0.2× 76 0.5× 306 4.4× 9 0.2× 34 0.8× 42 509

Countries citing papers authored by Ana Matos

Since Specialization
Citations

This map shows the geographic impact of Ana Matos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Matos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Matos more than expected).

Fields of papers citing papers by Ana Matos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Matos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Matos. The network helps show where Ana Matos may publish in the future.

Co-authorship network of co-authors of Ana Matos

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Matos. A scholar is included among the top collaborators of Ana Matos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Matos. Ana Matos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niehaus, Dana, Ana Matos, Timothy D. Henry, et al.. (2025). Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction. American Heart Journal. 289. 57–66.
2.
Matos, Ana, et al.. (2024). Pattern Recognition in Older Adults’ Activities of Daily Living. Future Internet. 16(12). 476–476.
3.
Henriques, Carla, Ana Matos, Miguel Castelo‐Branco, et al.. (2023). The relationship between acute pain and other types of suffering in pre-hospital trauma victims: An observational study. International Emergency Nursing. 71. 101375–101375. 5 indexed citations
4.
Henriques, Carla, Ana Matos, Elena Bartkienė, et al.. (2022). Marketing motivations influencing food choice in 16 countries: segmentation and cluster analysis. SHILAP Revista de lepidopterología. 4(1). 10–25. 2 indexed citations
6.
Santos, Margarida Reis, et al.. (2021). Trauma Prehospital Hypothermia Prevention and Treatment: An Observational Study. Journal of Trauma Nursing. 28(3). 194–202. 12 indexed citations
7.
Jesús, Diogo, Maddalena Larosa, Carla Henriques, et al.. (2021). Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Annals of the Rheumatic Diseases. 80(12). 1568–1574. 33 indexed citations
8.
Jesús, Diogo, Maddalena Larosa, Carla Henriques, et al.. (2021). Definition of low disease activity state based on the SLE-DAS: derivation and validation in a multicentre real-life cohort. Lara D. Veeken. 61(8). 3309–3316. 18 indexed citations
9.
Faria, Bernardo, Qingqing Cai, Carla Henriques, et al.. (2020). Arteriolar C4d in IgA Nephropathy: A Cohort Study. American Journal of Kidney Diseases. 76(5). 669–678. 29 indexed citations
10.
Matos, Ana, et al.. (2020). Ultra-Early Versus Early Aneurysm Surgery After Subarachnoid Hemorrhage: A Retrospective Outcome Analysis. SHILAP Revista de lepidopterología. 39(2). 95–100.
11.
Abreu, Luíz Carlos de, et al.. (2019). Application of Risks Scores in Acute Coronary Syndromes. How Does ProACS Hold Up Against Other Risks Scores?. Arquivos Brasileiros de Cardiologia. 113(1). 20–30. 1 indexed citations
12.
Jesús, Diogo, Ana Matos, Carla Henriques, et al.. (2019). Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Annals of the Rheumatic Diseases. 78(3). 365–371. 96 indexed citations
13.
Jesús, Diogo, Ana Matos, Carla Henriques, et al.. (2019). THU0267 THE SLE DISEASE ACTIVITY SCORE (SLE-DAS) ENABLES ACCURATE DEFINITIONS OF SLE REMISSION AND LDA AS ACHIEVABLE TARGETS IN DISEASE MANAGEMENT. Annals of the Rheumatic Diseases. 78. 411–412. 2 indexed citations
14.
Jesús, Diogo, Marília Rodrigues, Ana Matos, et al.. (2019). Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36–month prospective cohort study of 334 patients. Lupus. 28(5). 607–612. 25 indexed citations
15.
Henriques, Carla, et al.. (2018). Complications of fluidotherapy in patients with acute pancreatitis: A contribution. SHILAP Revista de lepidopterología. 23–31. 1 indexed citations
16.
Pereira, Jorge, et al.. (2015). Accuracy of ultrasound in the diagnosis of acute cholecystitis with coexistent acute pancreatitis. European Journal of Trauma and Emergency Surgery. 43(1). 79–83. 6 indexed citations
17.
Faria, Bernardo, Carla Henriques, Ana Matos, et al.. (2014). Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression. Clinical & Experimental Immunology. 179(2). 354–361. 43 indexed citations
18.
Fugikawa-Santos, Lucas, Bruno Rodrigues, Davide Moreira, et al.. (2012). Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome. EP Europace. 14(6). 882–888. 11 indexed citations
19.
Peres, Emanuel, et al.. (2010). Spontaneous Fluctuations between Diagnostic and Nondiagnostic ECGs in Brugada Syndrome Screening: Portuguese Family with Brugada Syndrome. Annals of Noninvasive Electrocardiology. 15(4). 337–343. 5 indexed citations
20.
Matos, Ana, J. Moutinho, Daniela Pinto, & Rui Medeiros. (2005). The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. European Journal of Cancer Prevention. 14(5). 485–491. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026